Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03442556
Title Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors University of Washington
Indications

prostate adenocarcinoma

Therapies

Carboplatin + Docetaxel + Rucaparib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST